S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
NASDAQ:PTGX

Protagonist Therapeutics Price Target, Predictions & Analyst Ratings

$23.09
-0.54 (-2.29 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.95
Now: $23.09
$24.41
50-Day Range
$19.02
MA: $22.02
$25.13
52-Week Range
$5.30
Now: $23.09
$25.65
Volume272,696 shs
Average Volume446,737 shs
Market Capitalization$883.35 million
P/E RatioN/A
Dividend YieldN/A
Beta1.56

Analyst Ratings

Protagonist Therapeutics (NASDAQ:PTGX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Protagonist Therapeutics in the last 12 months. Their average twelve-month price target is $36.25, predicting that the stock has a possible upside of 56.99%. The high price target for PTGX is $53.00 and the low price target for PTGX is $27.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
PTGX Consensus Rating: BuyBuyBuyBuy
PTGX Consensus Rating Score: 3.003.003.003.00
PTGX Analyst Ratings: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
PTGX Consensus Price Target: $36.25$36.43$31.20$30.00
PTGX Price Target Upside: 56.99% upside111.18% upside92.81% upside111.39% upside

Protagonist Therapeutics (NASDAQ:PTGX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Protagonist Therapeutics (NASDAQ:PTGX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/6/2021JPMorgan Chase & Co.Initiated CoverageOverweight$35.00N/A
12/16/2020Piper SandlerInitiated CoverageOverweight$53.00N/A
12/7/2020BMO Capital MarketsBoost Price Target$37.00 ➝ $46.00High
9/18/2020HC WainwrightBoost Price TargetBuy$28.00 ➝ $33.00High
7/15/2020Jefferies Financial GroupInitiated CoverageBuy$27.00High
5/22/2020SVB LeerinkBoost Price TargetOutperform$17.00 ➝ $30.00High
5/11/2020NomuraBoost Price TargetBuy$29.00 ➝ $33.00Medium
5/11/2020Nomura InstinetBoost Price TargetBuy$29.00 ➝ $33.00Medium
8/11/2019Nomura SecuritiesReiterated RatingBuy$29.00Low
5/8/2019Stifel NicolausUpgradeHold ➝ Buy$11.00 ➝ $17.00High
6/6/2018BarclaysDowngradeOverweight ➝ Equal Weight$18.00Low
(Data available from 1/26/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.